ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a

Source URL: www.ctc.usyd.edu.au

• Bristol-Myers Squibb
• Cetuximab
• Eli Lilly and Company
• Cancer treatments
• Chemotherapy
• KRAS
• Colorectal cancer
• Abituzumab
• Panitumumab